Company news from the 10/03/06 News Brief

Share this article:
TAP Pharmaceutical Products has agreed to a co-promotion agreement with Novartis Pharmaceuticals Corporation for Famvir (famciclovir), an oral antiviral prescription medication. Under the terms of the agreement, TAP will be responsible for promoting Famvir to the obstetrician/gynecology (OB/GYN) medical community. Financial terms of the agreement were not disclosed.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions